1

Covid-19

Student

University

Course

Professor

Date
 2

Covid-19

Neurological Implications of Corona Virus Disease 2019 (COVID-19) Infection

Introduction

Corona Virus Disease 2019 (COVID-19) epidemic originated in Wuhan, China, causing

worldwide tension. The virus is a Severe Acute Respiratory Syndrome Corona Virus two

(SARS-CoV-2) (Wu et al., 2020). More to respiratory and systemic symptoms, it was recently

noted that 36.4% of COVID-19 patients contract neurological complications that include

headache, paresthesia, and unconsciousness. The more sickly patients are more vulnerable to

developing neurological problems compared to patients with minor infections. Moreover,

autopsy results have disclosed partial neuron degeneration and brain tissue edema in those who

succumb to COVID-19. These complications may remain even after complete treatment of

COVID-19, which is an added problem.

Nervous System Impact on Infection With COVID-19

On 4th March 2020, Beijing Ditan Hospital reported a viral encephalitis case due to

Corona Virus affecting the Central Nervous System (CNS). Experts discovered SARS-CoV-2

presence in the cerebrospinal fluid through the genetic material sequence (Wu et al., 2020). It

reveals that COVID-19 damages the Central Nervous System. With the rise in the COVID-19

epidemic, medics need to be informed of the outcomes of COVID-19 on the CNS. In COVID-19

patients, neurological infections have been increasingly detected with less neuropathological

analysis, microthrombi documentation and severe infarcts, hypoxic alterations without definite

pathology, or lymphocytic filtration in the brainstem (Wu et al., 2020). The numerous viral

infections damage the CNS's function and structure, including serious encephalitis caused by

viral disease, infectious toxic encephalopathy due to serious viral infections, and critical severe
 3

demyelinating lesions occurring following viral infections. Some neurotropic viruses can attack

nervous tissues leading to astrocytes in the CNS, microglia infections, and immune-functioning

macrophages.

Corona Virus has an approximate diameter of a hundred nanometres and has a spherical

or oval shape. With observation by an electron microscope, the stained virus molecules are

typically crown-like. Corona Virus is a single-strand RNA virus harboring big genetic data in the

currently identified RNA virus (Wu et al., 2020). The pathogenic matter of the recent pneumonia

infection is the CoV 2019 (SARS-CoV2), the seventh known Corona Virus that infects human

beings. The most familiar types of Corona Virus infections causing nervous system damage are

discussed.

SARS-CoV: Severe acute respiratory syndrome (SARS) means a respiratory infection

transmitted by SARS-CoV originating from Asian counties. It has a characteristic severe initial

and is intensely infectious, a significant threat to humans (Wu et al., 2020). The primary

symptoms of SARS are dry cough, chills, fever, and breathing difficulties. In serious cases, it

may lead to respiratory failure and death. Additionally, SARS-CoV can cause neurological

infections like polyneuropathy, aortic ischemia, and encephalitis. Autopsy research demonstrates

that cerebral edema plus meningeal vasodilation are observed in SARS occurrences. Moreover,

filtration of lymphocytes with monocytes in the vessels, neural ischemic changes, demyelination

of axons, and SARS-CoV viruses, and genetic material sequencing are discovered in the brain.

MERS-CoV: Middle East Respiratory Syndrome (MERS) is transmitted by MERS-CoV,

originating out of bats plus camels. MERS-CoV infection patients often show pneumoniac

symptoms, like myalgia, fever, dyspnea, and coughs. Serious cases contribute to Acute

Respiratory Distress Syndrome (ARDS), multi-organ failure, sepsis, and eventually succumbing.
 4

MERS-CoV is neuroinvasive, and past research found that 25.7% of MERS patients can be

insane, and 8.6% of the patients develop convulsions (Wu et al., 2020). It is also reported that in

the process, a fifth of MERS-CoV infection patients display neurological signs. They include

unconsciousness, ischemia, paralysis, Guillain-Barre syndrome, plus neuropathy infections.

Surprisingly, the neurological complications do not have respiratory problems but delayed by

few weeks.

SARS-CoV-2: The resemblance in genes in SARS-CoV with SARS-CoV-2 is 80%, and

the relation to MERS-CoV is 96%. SARS-CoV-2 patients have varying symptoms, ranging from

feverish or gentle coughs to pneumonia and extended multiple organ function involvement, with

a death rate of 2% to 4% (Wu et al., 2020). Currently, medical records display that few COVID-

19 patients develop intracranial infections like epilepsy, headaches, and unconsciousness.

Additionally, numerous COVID-19 victims experience a gradual drop of taste or smell. Anosmia

and dysgeusia are likely to be seen in COVID-19 victims. Few people experience COVID-19-

symptoms later following displaying neurological signs and symptoms.

Beijing Ditan Hospital recently recorded a viral encephalitis case resulting from the

coronavirus affecting the CNS (Wu et al., 2020). The researchers discovered SARS-CoV-2

present in cerebrospinal fluid. The new pneumonia viruses can lead to serious harm to the

nervous system. Therefore, other pathogenic bacteria can damage the blood-to-brain blockage.

Eventually, intracranial diseases can lead to visual loss, headaches, limb convulsions, and

projectile vomiting in COVID-19 patients with acute symptoms.

Nervous System Infections Related to Corona Virus Infections

Viral Encephalitis: Encephalitis is the brain parenchyma inflammatory lesions

transmitted by pathogens, including nerve tissue lesions plus neuronal damage (Wu et al., 2020).
 5

The characteristics are acute onset and familiar symptoms, including vomiting, headaches, high

fever, and unconsciousness. In this pneumonia epidemic, the Beijing Ditan Hospital medical

team discovered SARS-CoV-2 presence in cerebrospinal fluid of COVID-19 victims by genetic

material progression and medically verified viral encephalitis. This confirmation provides a solid

ground for Corona Virus causing encephalitis.

Infectious toxic encephalopathy: Infectious toxic encephalopathy (acute toxic

encephalitis) is a correctable cerebral disorder created by hypoxia, system toxemia, and

metabolic problems during acute infections (Wu et al., 2020). The typical changes in this illness

are cerebral edema, without inflammation on the cerebrospinal fluid inspection. Its signs are

diverse and complex. Victims having gentle infections develop dysphoria, headaches, delirium,

and mental disorders. Severely affected patients experience coma, disorientation, paralysis, and

unconsciousness. Severe viral infections are also a great reason, with respiratory infections

caused by Corona Virus. COVID-19 patients usually develop viremia and acute hypoxia, which

causes toxic encephalopathy. Close to 40% of COVID-19 patients experience headaches,

unconsciousness, and other brain disorders. Autopsy analysis found out that edema is found in

the brain tissues of COVID-19 victims. All the observations collectively prove that COVID-19

causes infectious toxic encephalopathy.

Acute cerebrovascular disease: Some evidence shows that respiratory problems are

causative factors for Acute Cerebrovascular Disease (Wu et al., 2020). Research from practical

mouse models shows that the influenza virus increases serious brain damage by starting a

cytokine cascade while increasing cerebral hemorrhage threat after treating with a plasminogen

activator. The Corona Virus infections, mainly SARS-CoV-2, are said to lead to cytokine storm

syndromes, one factor that Corona Virus causes acute cerebrobasilar disease. Additionally,
 6

seriously sick patients having acute SARS-CoV-2 infections usually display an increased rate of

platelets reduction. This exposes the patients to acute cerebrovascular disease. During Corona

Virus infections, patients vulnerable to developing the cerebrovascular disease are likely to be

informed concerning the development of acute cerebrovascular.

A Study to Identify Microvascular and Hypoxic Damage: Emerging Neuropathological

Effects in COVID-19

A report of the neuropathology of two typical COVID-19 victims with similar cases of

neocortical infarcts and less hemorrhagic and non-hemorrhagic white matter lesions is issued

(Jaunmuktane et al., 2020). It suggests a trending pattern of alteration characteristics recorded

radiologically. The first patient was a male in his fifties suffering from cardiac arrest prior to

veno-venous ExtraCorporeal Membrane Oxygenation (vvECMO) and died of multiple focal

infarctions. The real reason for the large right Middle Cerebral Artery (MCA) plus the bilateral

Posterior Cerebral Artery (PCA) blockage is unidentified. Thromboembolic arising from

pulmonary embolus gets eliminated because of the closed foramen ovale.

The second patient was a female in her sixties and in tubes plus ventilation but remained

unresponsive following disconnection and succumbed to multiple organ non-performance

(Jaunmuktane et al., 2020). The bilateral pallidal infarcts were created by hypoxia. Pathogens of

the cortical plus white matter microlesions include microbleeds including viral vascular injury,

immunity mediation, or hypoxia-related to hypotension, or thromboembolism. MRI relation to

pathology displayed that leptomeningeal hyperintensity corresponds to lymphohistiocytic

inflammation. Neuronophagia, microglial nodules, plus vascular injury, include signs of

vasculitis, apart from the blockages were unidentified, and inflammation in the medulla close to

other neurological diseases victims.

 7

Conclusion

In conclusion, according to the research, the complications of neuropathology in COVID-

19 and the problems in unraveling hypoxic and anoxic modifications are responsible for the

neurological infections in each victim. The new knowledge gained is that some medicines like

ECMO increase the threat of neurological conditions when treating COVID-19. In future

neuropathological analyses, we hope that mechanisms that lead to damage to tissues in COVID-

19 will be explained to allow appropriate and timely plus treatment choices. Better medications,

too, that consider the neurological effects have to be researched and analyzed.

Corona Virus infections can damage the nervous system, and medics believe that Corona

Virus can change the condition to persistent diseases leading to neurological disorders.

Conclusively, COVID-19 victims must be monitored earlier for neurological symptoms that

include headaches, paresthesia, unconsciousness, plus other pathological symptoms. Opportune

analyses of cerebrospinal fluid and consciousness plus managing infections relating to neurology

complications are critical to improving critically sick patients' prognosis. Before concluding the

total recovery of covid-19 patients, doctors must monitor the cerebral reaction to the medications

used and their effects.

 8

References

Jaunmuktane, Z., Mahadeva, U., Green, A., Sekhawat, V., Barrett, N. A., Childs, L., ... &

Brandner, S. (2020). Microvascular injury and hypoxic damage: emerging

neuropathological signatures in COVID-19. Acta Neuropathologica, 140(3), 397-400.

Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., ... & Yang, C. (2020). Nervous

system involvement after infection with COVID-19 and other coronaviruses. Brain,

behavior, and immunity, 87, 18-22.